Testing for PCOS
Diagnose PCOS in adult women when 2 of 3 Rotterdam criteria are met: (1) androgen excess (clinical or biochemical), (2) ovulatory dysfunction, and (3) polycystic ovaries on ultrasound—but only after excluding thyroid disease, hyperprolactinemia, and nonclassic congenital adrenal hyperplasia. 1
Essential Screening Tests (All Women)
Before diagnosing PCOS, you must exclude mimicking disorders with these three mandatory tests 1:
- TSH (thyroid disease)
- Prolactin (hyperprolactinemia)
- 17-hydroxyprogesterone (17-OHP) (nonclassic congenital adrenal hyperplasia, found in 1.5-6.8% of women with androgen excess)
Diagnostic Criteria Components
1. Androgen Excess Assessment
Clinical hyperandrogenism should be systematically documented 1:
- Hirsutism using Ferriman-Gallwey score (standardized assessment tool)
- Acne (moderate to severe)
- Androgenic alopecia (male pattern hair loss)
- Acanthosis nigricans and skin tags (markers of insulin resistance)
Biochemical hyperandrogenemia 1, 2:
- Total or free testosterone (primary test)
- Free androgen index (calculated as: total testosterone ÷ SHBG × 100)
- Consider androstenedione and DHEA-S if initial tests inconclusive
- Do not use anti-Müllerian hormone (AMH) for diagnosis 2
2. Ovulatory Dysfunction
Menstrual history is the primary screening tool 1:
- Oligomenorrhea (cycles >35 days apart)
- Amenorrhea (absence of menses)
- In women with regular cycles who are seeking fertility, consider midluteal progesterone to confirm ovulation 1
3. Polycystic Ovary Morphology
Transvaginal ultrasound criteria 1:
- At least one ovary with ≥12 follicles measuring 2-9 mm, OR
- Ovarian volume >10 mL
- Must be in the absence of a dominant follicle >10 mm
Important caveat: You do not need to perform androgen assays or ultrasound if the patient already meets two criteria clinically based on history and physical examination 1.
Age-Specific Diagnostic Modifications
Adolescents
Diagnosis requires both of the following 1, 3, 4:
- Persistent menstrual irregularity (≥2 years post-menarche)
- Clinical and/or biochemical hyperandrogenism
- Polycystic ovarian morphology on ultrasound (too common in normal adolescents)
- AMH levels (limited specificity in this age group)
- Acne alone (too common in normal puberty)
The rationale: oligomenorrhea, polycystic ovaries, and elevated androgens are physiologic during early puberty, making these features non-specific 1.
Perimenopausal/Menopausal Women
No validated diagnostic criteria exist for this population 1. Make a presumptive diagnosis based on:
- Well-documented history of oligomenorrhea AND hyperandrogenism during reproductive years
- Polycystic ovarian morphology on ultrasound (if present) provides supportive evidence, though less likely in menopause
Additional Investigations When Indicated
Order more extensive testing if the patient presents with 1:
- Virilization (clitoromegaly, voice deepening, increased muscle mass) → consider androgen-secreting tumor
- Amenorrhea with severe phenotype → broader differential workup
- Proximal muscle weakness → screen for Cushing's syndrome
- Frontal bossing → screen for acromegaly
Practical Algorithm
- Take menstrual history and perform physical examination documenting hirsutism, acne, alopecia, acanthosis nigricans
- Order mandatory screening labs: TSH, prolactin, 17-OHP
- If hyperandrogenism suspected clinically: measure total/free testosterone or free androgen index
- If only one criterion met clinically: perform transvaginal ultrasound to assess ovarian morphology
- Document which 2 of 3 Rotterdam criteria are present to confirm diagnosis
Common Pitfalls
- Don't routinely screen with ultrasound or androgens if clinical history already establishes 2 criteria 1
- Don't diagnose PCOS in adolescents based on ultrasound findings alone 2, 3—this leads to overdiagnosis
- Don't use AMH for diagnosis despite its association with PCOS 2
- Don't forget the mandatory exclusion tests (TSH, prolactin, 17-OHP)—PCOS is a diagnosis of exclusion 1
- Document the specific features leading to diagnosis, as different phenotypes carry different metabolic and reproductive risks 1